Real-World Effectiveness of Lung Cancer Screening Using Deep Learning-Based Counterfactual Prediction
The benefits and harms of lung cancer screening (LCS) for patients in the real-world clinical setting have been argued. Recently, discriminative prediction modeling of lung cancer with stratified risk factors has been developed to investigate the real-world effectiveness of LCS from observational data. However, most of these studies were conducted at the population level that only measured the difference in the average outcome between groups. In this study, we built counterfactual prediction models for lung cancer risk and mortality and examined for individual patients whether LCS as a hypothetical intervention reduces lung cancer risk and subsequent mortality. We investigated traditional and deep learning (DL)-based causal methods that provide individualized treatment effect (ITE) at the patient level and evaluated them with a cohort from the OneFlorida+ Clinical Research Consortium. We further discussed and demonstrated that the ITE estimation model can be used to personalize clinical decision support for a broader population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:310 |
|---|---|
| Enthalten in: |
Studies in health technology and informatics - 310(2024) vom: 25. Jan., Seite 419-423 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Feng, Zheng [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Causal effect estimation |
|---|
| Anmerkungen: |
Date Completed 26.01.2024 Date Revised 26.01.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3233/SHTI230999 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36760261X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36760261X | ||
| 003 | DE-627 | ||
| 005 | 20240126232230.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240125s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3233/SHTI230999 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1271.xml |
| 035 | |a (DE-627)NLM36760261X | ||
| 035 | |a (NLM)38269837 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Feng, Zheng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Real-World Effectiveness of Lung Cancer Screening Using Deep Learning-Based Counterfactual Prediction |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.01.2024 | ||
| 500 | |a Date Revised 26.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The benefits and harms of lung cancer screening (LCS) for patients in the real-world clinical setting have been argued. Recently, discriminative prediction modeling of lung cancer with stratified risk factors has been developed to investigate the real-world effectiveness of LCS from observational data. However, most of these studies were conducted at the population level that only measured the difference in the average outcome between groups. In this study, we built counterfactual prediction models for lung cancer risk and mortality and examined for individual patients whether LCS as a hypothetical intervention reduces lung cancer risk and subsequent mortality. We investigated traditional and deep learning (DL)-based causal methods that provide individualized treatment effect (ITE) at the patient level and evaluated them with a cohort from the OneFlorida+ Clinical Research Consortium. We further discussed and demonstrated that the ITE estimation model can be used to personalize clinical decision support for a broader population | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Causal effect estimation | |
| 650 | 4 | |a counterfactual | |
| 650 | 4 | |a deep learning | |
| 650 | 4 | |a real-world data | |
| 700 | 1 | |a Chen, Zhaoyi |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Prosperi, Mattia |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Hiren |e verfasserin |4 aut | |
| 700 | 1 | |a Braithwaite, Dejana |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Yonghui |e verfasserin |4 aut | |
| 700 | 1 | |a Bian, Jiang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Studies in health technology and informatics |d 1991 |g 310(2024) vom: 25. Jan., Seite 419-423 |w (DE-627)NLM091691567 |x 1879-8365 |7 nnns |
| 773 | 1 | 8 | |g volume:310 |g year:2024 |g day:25 |g month:01 |g pages:419-423 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3233/SHTI230999 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 310 |j 2024 |b 25 |c 01 |h 419-423 | ||